Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000757062 | SCV000885150 | pathogenic | not provided | 2017-09-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001051783 | SCV001215961 | pathogenic | Cerebral cavernous malformation 2 | 2019-10-03 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in CCM2 are known to be pathogenic (PMID: 2468908, 14624391, 17160895, 18300272). This variant has not been reported in the literature in individuals with CCM2-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Gly24Valfs*13) in the CCM2 gene. It is expected to result in an absent or disrupted protein product. |